Skin cancer care varies by specialist – new study aims to find out why
NCT ID NCT07571031
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will show 20 cases of basal cell carcinoma (the most common skin cancer) to doctors from different specialties—dermatologists, oncologists, surgeons, and radiation therapists—to see how they classify and treat the same cases. The goal is to understand why there is so much variation in care and to work toward more consistent treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to more consistent staging and treatment decisions for basal cell carcinoma across different medical specialties.
- What could go wrong
- This is a small, early-stage observational study with only 20 participants, so results may not apply broadly. It does not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Botox before the knife: could a Pre-Surgery injection lead to Better-Looking scars?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- New skin patch could speed recovery after skin cancer removal
- AI reads skin lesions to predict cancer aggressiveness
- Needle-Free light therapy shows promise for common skin cancer
- Snap and measure: new photo method tracks nose shape after skin cancer surgery